Want to see FR:ALCRB full AI Analyst Report?
ALCRB Stock Chart & Stats
€10.37
€0.33(5.00%)
At close: 4:00 PM EST
€10.37
€0.33(5.00%)
Day’s Range― - ―
52-Week Range€5.02 - €15.84
Previous CloseN/A
Volume21.76K
Average Volume (3M)54.14K
Market Cap
€97.19M
Enterprise Value€76.42M
Total Cash (Recent Filing)€49.96M
Total Debt (Recent Filing)€31.65M
Price to Earnings (P/E)―
Beta1.29
Next Earnings
Sep 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.03
Shares Outstanding16,905,630
10 Day Avg. Volume34,450
30 Day Avg. Volume54,144
Financial Highlights & Ratios
PEG Ratio-1.81
Price to Book (P/B)0.97
Price to Sales (P/S)60.79
P/FCF Ratio-10.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-1.12
Revenue Forecast (FY)€6.00M
Bulls Say, Bears Say
Bulls Say
Proprietary Enzymatic TechCarbios’ core proprietary enzyme platform for PET depolymerization is a durable competitive asset. It targets structural demand for circular plastics across packaging and textiles, supports licensing/royalty models and industrial partnerships, and can scale without commodity R&D cycles.
Low Financial LeverageA strong equity base and minimal debt materially reduce solvency risk while industrializing new plants. This financial flexibility provides runway for capex and scale-up, allows selective partnerships, and lowers refinancing pressure versus highly leveraged peers.
Reduced Cash BurnMaterial reduction in cash outflows signals stronger capital discipline or slower capex, extending runway and lowering near-term funding urgency. If sustained, this improves viability of commercialization plans and reduces dependency on rapid external financing.
Bears Say
Sustained UnprofitabilityLarge recurring operating and net losses show the business has not reached profitable scale. Continued negative margins erode equity, limit reinvestment capacity, and mean success depends on achieving significant revenue scale or margin improvement that is not yet evident.
Negative Cash GenerationOngoing negative operating and free cash flow require external funding or partner financing to sustain operations and industrial rollouts. Reliance on capital raises risks dilution and creates execution conditionality tied to investor sentiment or partner funding timelines.
Very Small Revenue ScaleDespite a strong percentage increase, absolute revenue remains tiny relative to costs and losses. This indicates limited commercial traction to date; durable profitability depends on converting pilot projects and licenses into substantial, recurring revenue streams.
Carbios SA News
ALCRB FAQ
What was Carbios SA’s price range in the past 12 months?
Carbios SA lowest stock price was €5.02 and its highest was €15.84 in the past 12 months.
What is Carbios SA’s market cap?
Carbios SA’s market cap is €97.19M.
When is Carbios SA’s upcoming earnings report date?
Carbios SA’s upcoming earnings report date is Sep 24, 2026 which is in 81 days.
How were Carbios SA’s earnings last quarter?
Currently, no data Available
Is Carbios SA overvalued?
According to Wall Street analysts Carbios SA’s price is currently Overvalued.
Does Carbios SA pay dividends?
Carbios SA does not currently pay dividends.
What is Carbios SA’s EPS estimate?
Carbios SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Carbios SA have?
Carbios SA has 16,905,630 shares outstanding.
What happened to Carbios SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Carbios SA?
Currently, no hedge funds are holding shares in FR:ALCRB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Carbios SA
Carbios SAS, a pioneering French green chemistry company, is at the forefront of developing industrial bioprocesses for the biodegradation and biorecycling of various polymers. Among its key innovations is EVANESTO, an enzymatic solution specifically designed to break down single-use plastics made from polylactic acid (PLA). The company also specializes in the enzymatic recycling of polyethylene terephthalate (PET). Furthermore, Carbios champions PLA, a biosourced and biodegradable plastic polymer widely employed in sectors like food packaging, disposable tableware, electronics, and medical applications. A fundamental objective is to transform plastic waste back into valuable, reusable plastic materials. Its innovative solutions are not limited to France but are also exported internationally. Notably, Carbios SAS maintains a crucial development agreement with Novozymes for the production of enzymes vital to recycling PET plastics and fibers. Established in 2011, Carbios SAS operates from its headquarters in Saint-Beauzire, France.
Technical Analysis
Options Prices
Currently, No data available
---